231 related articles for article (PubMed ID: 31395736)
1. MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers.
Srinivasan G; Williamson EA; Kong K; Jaiswal AS; Huang G; Kim HS; Schärer O; Zhao W; Burma S; Sung P; Hromas R
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17438-17443. PubMed ID: 31395736
[TBL] [Abstract][Full Text] [Related]
2. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
3. FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair.
Kais Z; Rondinelli B; Holmes A; O'Leary C; Kozono D; D'Andrea AD; Ceccaldi R
Cell Rep; 2016 Jun; 15(11):2488-99. PubMed ID: 27264184
[TBL] [Abstract][Full Text] [Related]
4. Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.
Srinivasan G; Sidhu GS; Williamson EA; Jaiswal AS; Najmunnisa N; Wilcoxen K; Jones D; George TJ; Hromas R
Cancer Chemother Pharmacol; 2017 Oct; 80(4):861-867. PubMed ID: 28756516
[TBL] [Abstract][Full Text] [Related]
5. MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation.
Chen S; Srinivasan G; Jaiswal A; Williamson EA; Li L; Arris D; Zhou D; Xu M; Hromas R
Exp Hematol; 2024 Jan; 129():104123. PubMed ID: 37875176
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of oncogenic chromosomal translocations.
Byrne M; Wray J; Reinert B; Wu Y; Nickoloff J; Lee SH; Hromas R; Williamson E
Ann N Y Acad Sci; 2014 Mar; 1310():89-97. PubMed ID: 24528169
[TBL] [Abstract][Full Text] [Related]
7. Drugging the Cancers Addicted to DNA Repair.
Nickoloff JA; Jones D; Lee SH; Williamson EA; Hromas R
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 28521333
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells.
Ciccone MA; Adams CL; Bowen C; Thakur T; Ricker C; Culver JO; Maoz A; Melas M; Idos GE; Jeyasekharan AD; Matsuo K; Roman LD; Gruber SB; McDonnell KJ
Gynecol Oncol; 2020 Dec; 159(3):869-876. PubMed ID: 33032822
[TBL] [Abstract][Full Text] [Related]
9. Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality.
Kornepati AVR; Boyd JT; Murray CE; Saifetiarova J; de la Peña Avalos B; Rogers CM; Bai H; Padron AS; Liao Y; Ontiveros C; Svatek RS; Hromas R; Li R; Hu Y; Conejo-Garcia JR; Vadlamudi RK; Zhao W; Dray E; Sung P; Curiel TJ
Cancer Res; 2022 Jun; 82(11):2156-2170. PubMed ID: 35247877
[TBL] [Abstract][Full Text] [Related]
10. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability.
Choi YE; Pan Y; Park E; Konstantinopoulos P; De S; D'Andrea A; Chowdhury D
Elife; 2014 Apr; 3():e02445. PubMed ID: 24843000
[TBL] [Abstract][Full Text] [Related]
12. USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.
Lim KS; Li H; Roberts EA; Gaudiano EF; Clairmont C; Sambel LA; Ponnienselvan K; Liu JC; Yang C; Kozono D; Parmar K; Yusufzai T; Zheng N; D'Andrea AD
Mol Cell; 2018 Dec; 72(6):925-941.e4. PubMed ID: 30576655
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 deficiency and synthetic lethality in leukemias; not only gene mutation matters.
Piwocka K; Podszywałow-Bartnicka P; Skorski T
Postepy Biochem; 2018 Oct; 64(2):141-147. PubMed ID: 30656896
[TBL] [Abstract][Full Text] [Related]
14. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
[TBL] [Abstract][Full Text] [Related]
15. CtIP-mediated resection is essential for viability and can operate independently of BRCA1.
Polato F; Callen E; Wong N; Faryabi R; Bunting S; Chen HT; Kozak M; Kruhlak MJ; Reczek CR; Lee WH; Ludwig T; Baer R; Feigenbaum L; Jackson S; Nussenzweig A
J Exp Med; 2014 Jun; 211(6):1027-36. PubMed ID: 24842372
[TBL] [Abstract][Full Text] [Related]
16. EEPD1 Rescues Stressed Replication Forks and Maintains Genome Stability by Promoting End Resection and Homologous Recombination Repair.
Wu Y; Lee SH; Williamson EA; Reinert BL; Cho JH; Xia F; Jaiswal AS; Srinivasan G; Patel B; Brantley A; Zhou D; Shao L; Pathak R; Hauer-Jensen M; Singh S; Kong K; Wu X; Kim HS; Beissbarth T; Gaedcke J; Burma S; Nickoloff JA; Hromas RA
PLoS Genet; 2015 Dec; 11(12):e1005675. PubMed ID: 26684013
[TBL] [Abstract][Full Text] [Related]
17. Homologous recombination deficiency real-time clinical assays, ready or not?
Fuh K; Mullen M; Blachut B; Stover E; Konstantinopoulos P; Liu J; Matulonis U; Khabele D; Mosammaparast N; Vindigni A
Gynecol Oncol; 2020 Dec; 159(3):877-886. PubMed ID: 32967790
[TBL] [Abstract][Full Text] [Related]
18. Nitric Oxide: Genomic Instability And Synthetic Lethality.
Yakovlev VA
Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162271
[TBL] [Abstract][Full Text] [Related]
19. CtIP-Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress.
Przetocka S; Porro A; Bolck HA; Walker C; Lezaja A; Trenner A; von Aesch C; Himmels SF; D'Andrea AD; Ceccaldi R; Altmeyer M; Sartori AA
Mol Cell; 2018 Nov; 72(3):568-582.e6. PubMed ID: 30344097
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting and patient selection for cancers with homologous recombination defects.
Talens F; Jalving M; Gietema JA; Van Vugt MA
Expert Opin Drug Discov; 2017 Jun; 12(6):565-581. PubMed ID: 28425306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
